Skip to main content
Back to Show
PBS News Hour

What’s keeping biosimilar drugs from the U.S. market?

NewsHour looks at a revolutionary class of drugs called "biologics." Americans have been paying more for their benefits than patients in Europe or Asia some say, because the "generic" versions or "biosimilars" have not hit the U.S. market. Dr. Emily Senay looks into why there's a delay and when American consumers can expect discounts.

Support Provided By
Season
February 4, 2026 - PBS News Hour full episode
56:44
February 4, 2026 - PBS News Hour full episode
February 3, 2026 - PBS News Hour full episode
57:46
February 3, 2026 - PBS News Hour full episode
February 2, 2026 - PBS News Hour full episode
56:44
February 2, 2026 - PBS News Hour full episode
January 30, 2026 - PBS News Hour full episode
57:46
January 30, 2026 - PBS News Hour full episode
January 29, 2026 - PBS News Hour full episode
57:46
January 29, 2026 - PBS News Hour full episode
January 28, 2026 - PBS News Hour full episode
57:46
January 28, 2026 - PBS News Hour full episode
January 23, 2026 - PBS News Hour full episode
57:46
January 23, 2026 - PBS News Hour full episode
January 27, 2026 - PBS News Hour full episode
57:46
January 27, 2026 - PBS News Hour full episode
January 22, 2026 - PBS News Hour full episode
57:46
January 22, 2026 - PBS News Hour full episode
January 26, 2026 - PBS News Hour full episode
57:46
January 26, 2026 - PBS News Hour full episode
January 21, 2026 - PBS News Hour full episode
57:46
January 21, 2026 - PBS News Hour full episode
January 20, 2026 - PBS News Hour full episode
57:46
January 20, 2026 - PBS News Hour full episode
Active loading indicator